Great Place To Work and Fortune Name Chiesi Group No. 23 in 2024 World’s Best Workplaces™ List
- Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best Workplaces™
- The accolade reflects Chiesi's dedication to people’s well-being, continuous improvement, and creating a positive work environment
- Chiesi was also recently ranked in in the Best Workplaces in Europe™ 2024, Best Workplaces for Women™ in Greater China, and UK's Best Workplaces in BioPharma™, among others
Parma (Italy) November 14, 2024 – Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking 23rd on this year’s list.
This is the first time that Chiesi has been included in the GPTW global list, standing out as the first Italian company ever to achieve this honor. Headquartered in Parma, Italy, the Group has 31 affiliates worldwide and employs over 7,000 people, 56% of whom are women. More than 1,300 employees are dedicated to R&D.
“We are immensely proud to be the only European pharmaceutical company included in the World's Best Workplaces™ rankings. Being part of such a selective global list of only 25 companies is a source of huge motivation for continuous improvement.” said Giuseppe Accogli, Chief Executive Officer, Chiesi Group. “This placement stems from our firm commitment to our people's well-being, as it reflects their direct feedback and contribution in shaping Chiesi into a place where we all enjoy working. I believe this accolade will further increase our sense of pride and belonging to a company fully dedicated to serving patients around the world in everything we do”.
Great Place To Work® and Fortune’s annual list selects 25 global organizations that participated in Great Place To Work’s employee survey process, with 7.4 million responses received, representing 20 million employees worldwide. To be considered for the list, companies must be identified as outstanding global employers with recognition on at least five Best Workplaces™ lists in Asia, Europe, Latin America, Africa, North America, or Australia during 2023 or early 2024.
Reacting to the result, Giacomo Mazzariello, Chief Human Resources Officer, said, “Our talented global team is the cornerstone of our success. In all our locations around the world, we strive to create an environment where our people feel that Chiesi is their 'Happy Place'. We believe in human-centered leadership, and we are committed to make every voice matter. We strive for every team member to feel empowered to make a difference by bringing their authentic selves to work, implementing policies aiming at a concrete experience of work-life balance, or as we call it, (work-) Life Harmony. From closing the gender pay gap to fostering a culture of well-being and innovation, we’re not just achieving a ranking; we’re working towards an even brighter future. We are aiming to make a stronger, lasting impact together with our existing talents, and the new ones that will join us over time”.
In addition to today’s recognition, in 2024 Chiesi was also ranked as one of the top 10 Best Workplaces in Europe™, and it was recognized by Fortune as one of the Great Places to Work in Biopharma in the U.S., Best Workplaces for Women™ in Greater China, UK's Best Workplaces in BioPharma™, and UK's Best Workplaces for Development™, among other accolades.
About the Fortune World’s Best Workplaces™
Great Place To Work selected the World’s Best Workplaces by gathering and analyzing more than 7.4 million confidential survey responses, representing the experiences of 20 million employees worldwide at Great Place To Work Certified organizations. Organizations are assessed on their efforts to create great workplaces and positively impact people and communities across multiple countries around the world. Companies must have appeared on at least five Best Workplaces lists in Asia, Europe, Latin America, Africa, North America, or Australia during 2023 or early 2024, and have at least 5,000 employees worldwide, with 40% outside of its headquartered country. Read the full methodology.To be considered, all companies use the Great Place To Work Trust Index™ survey.
To learn more about the Best Workplaces in Europe™ list click here.
About Chiesi Group
Chiesi is research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.
By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035.
With over 85 years of experience, Chiesi is headquartered in Parma (Italy), with 31 affiliates worldwide, and counts more than 7,000 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.
